Biota Ltd. develops proprietary pharmaceutical and nutraceutical oral film strips.

Biota’s innovative AlgiFilm™ film strips are simply administered onto or under the tongue (sublingually) without use of water, and adhere at oral mucosa surface and afterwards dissolve slowly due to hydration by the saliva.

AlgiFilm™ proprietary formulations enable to accomplish active ingredients’ trans-mucosal absorption that increase bioavailability and improve safety and effectiveness.

AlgiFilm™ oral film strips comprising high-doses of water insoluble (hydrophobic) bioactive ingredients, such as oil-soluble vitamins, Cannabinoids, and Coenzyme Q10, are under development.

The platform technology is patent protected until 2040 in Japan, Europe, and India, and corresponding patent applications are pending in USA, and Canada.

Biota patents offer pharmaceutical companies important Life Cycle Management (LCM) opportunities by extending the patent lifespan of their APIs becoming off patent.